Hydrogen Repairs LPS-Induced Endothelial Progenitor Cells Injury via PI3K/AKT/eNOS Pathway

被引:8
作者
Mu, Qingjie [1 ,2 ]
Lv, Kaixuan [3 ]
Yu, Jielun [3 ,4 ,5 ]
Chu, Shangmin [3 ]
Zhang, Lichun [3 ]
Kong, Lingyu [6 ]
Zhang, Linlin [3 ]
Tian, Yan [7 ]
Jia, Xiaopeng [8 ]
Liu, Benhong [9 ]
Wei, Youzhen [10 ,11 ]
Yang, Nana [3 ,4 ,5 ]
机构
[1] Weifang Med Univ, Sch Clin Med, Weifang, Peoples R China
[2] Univ Hlth & Rehabil Sci, Qingdao, Peoples R China
[3] Weifang Med Univ, Sch Biosci & Technol, Weifang, Peoples R China
[4] Weifang Med Univ, Med Lab Anim Ctr, Weifang, Peoples R China
[5] Weifang Key Lab Anim Model Res Cardiovasc & Cerebr, Weifang, Peoples R China
[6] Weifang Med Univ, Sch Rehabil Med, Weifang, Peoples R China
[7] Tongji Univ, Shanghai East Hosp, Res Ctr Translat Med, Shanghai, Peoples R China
[8] Shandong Qilu Stem Cell Engn Co, Jinan, Peoples R China
[9] Dongying Peoples Hosp, Dept Resp, Dongying, Peoples R China
[10] Tongji Univ, Sch Med, East Hosp, Res Ctr Translat Med, Shanghai, Peoples R China
[11] Tongji Univ, Sch Med, East Hosp, Key Lab Arrhythmias Minist Educ China, Shanghai, Peoples R China
基金
中国国家自然科学基金;
关键词
endothelial progenitor cells; lung injury; hydrogen; PI3K; AKT; eNOS signaling pathway; lipopolysaccharide; ACUTE LUNG INJURY; RICH WATER; POLYMICROBIAL SEPSIS; OXIDATIVE STRESS; BONE-MARROW; LIPOPOLYSACCHARIDE; GAS; ANTIOXIDANT; ISCHEMIA; THERAPY;
D O I
10.3389/fphar.2022.894812
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Endotoxins and other harmful substances may cause an increase in permeability in endothelial cells (ECs) monolayers, as well as ECs shrinkage and death to induce lung damage. Lipopolysaccharide (LPS) can impair endothelial progenitor cells (EPCs) functions, including proliferation, migration, and tube formation. EPCs can migrate to the damaged area, differentiate into ECs, and participate in vascular repair, which improves pulmonary capillary endothelial dysfunction and maintains the integrity of the endothelial barrier. Hydrogen (H-2) contributes to the repairment of lung injury and the damage of ECs. We therefore speculate that H-2 protects the EPCs against LPS-induced damage, and it's mechanism will be explored. The bone marrow-derived EPCs from ICR Mice were treated with LPS to establish a damaged model. Then EPCs were incubated with H-2, and treated with PI3K inhibitor LY294002 and endothelial nitric oxide synthase (eNOS) inhibitor L-NAME. MTT assay, transwell assay and tube formation assay were used to detect the proliferation, migration and angiogenesis of EPCs. The expression levels of target proteins were detected by Western blot. Results found that H-2 repaired EPCs proliferation, migration and tube formation functions damaged by LPS. LY294002 and L-NAME significantly inhibited the repaired effect of H-2 on LPS-induced dysfunctions of EPCs. H-2 also restored levels of phosphor-AKT (p-AKT), eNOS and phosphor-eNOS (p-eNOS) suppressed by LPS. LY294002 significantly inhibited the increase of p-AKT and eNOS and p-eNOS expression exposed by H-2. L-NAME significantly inhibited the increase of eNOS and p-eNOS expression induced by H-2. H-2 repairs the dysfunctions of EPCs induced by LPS, which is mediated by PI3K/AKT/eNOS signaling pathway.
引用
收藏
页数:12
相关论文
共 50 条
  • [31] Fractalkine deficiency attenuates LPS-induced acute kidney injury and podocyte apoptosis by targeting the PI3K/Akt signal pathway
    Gong, Qiming
    Ma, Jingxue
    Kang, Hongli
    Pan, Xiuhong
    You, Yanwu
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2022, 26 (08) : 741 - 749
  • [32] Visfatin attenuates the ox-LDL-induced senescence of endothelial progenitor cells by upregulating SIRT1 expression through the PI3K/Akt/ERK pathway
    Ming, Guang-Feng
    Tang, Yong-Jun
    Hu, Kai
    Chen, Yao
    Huang, Wei-Hua
    Xiao, Jian
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2016, 38 (02) : 643 - 649
  • [33] Exogenous hydrogen sulfide reduces atrial remodeling and atrial fibrillation induced by diabetes mellitus via activation of the PI3K/Akt/eNOS pathway
    Xue, Xiaofei
    Ling, Xinyu
    Xi, Wang
    Wang, Pei
    Sun, Jianjun
    Yang, Qian
    Xiao, Jian
    MOLECULAR MEDICINE REPORTS, 2020, 22 (03) : 1759 - 1766
  • [34] Reduning Attenuates LPS-Induced Human Unmilical Vein Endothelial Cells (HUVECs) Apoptosis Through PI3K-AKT Signaling Pathway
    Wang, Ziyi
    Wang, Xuesong
    Guo, Zhe
    Liao, Haiyan
    Chai, Yan
    Wang, Ziwen
    Wang, Zhong
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [35] Silent information regulator 1 (SIRT1) promotes the migration and proliferation of endothelial progenitor cells through the PI3K/Akt/eNOS signaling pathway
    Li, Wei
    Du, Dayong
    Wang, Hang
    Liu, Yang
    Lai, Xiaohui
    Jiang, Feng
    Chen, Dong
    Zhang, Yanbin
    Zong, Jiaxin
    Li, Yuntian
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2015, 8 (03): : 2274 - 2287
  • [36] Eriodictyol Suppresses Gastric Cancer Cells via Inhibition of PI3K/AKT Pathway
    Shan, Hui
    Zhang, Xin
    Mi, Yalu
    Jia, Jihui
    Wang, Bo
    Yang, Qing
    PHARMACEUTICALS, 2022, 15 (12)
  • [37] Endothelial Progenitor Cells Promote Osteosarcoma Progression and Invasiveness via AKT/PI3K Signaling
    Doppelt-Flikshtain, Ofri
    Younis, Amin
    Tamari, Tal
    Ginesin, Ofir
    Shentzer-Kutiel, Talia
    Nikomarov, David
    Bar-Sela, Gil
    Coyac, Benjamin R.
    Assaraf, Yehuda G.
    Zigdon-Giladi, Hadar
    CANCERS, 2023, 15 (06)
  • [38] Artesunate ameliorates sepsis-induced acute lung injury by activating the mTOR/AKT/PI3K axis
    Zhang, Ensheng
    Wang, Jing
    Chen, Qian
    Wang, Zhaohao
    Li, Dong
    Jiang, Ning
    Ju, Xiuli
    GENE, 2020, 759
  • [39] Exendin-4 attenuates high glucose-induced endothelial progenitor cells dysfunction through the PI3-K/Akt/eNOS pathway
    Cao, Zheng
    Tu, Qiang
    Chen, Ping-Ying
    Yang, Yong
    Xie, Hua-Qiang
    Wu, Rui-Xia
    Xie, Hua
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2017, 10 (06): : 6774 - 6780
  • [40] Sinomenine promotes flap survival by upregulating eNOS and eNOS-mediated autophagy via PI3K/AKT pathway
    Zhang, Dupiao
    Jin, Chen
    Han, Tao
    Chen, Jianpeng
    Raza, Mazhar Ali
    Li, Baolong
    Wang, Liang
    Yan, Hede
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2023, 116